Ptc Therapeutics (PTCT) EBIT Margin (2012 - 2026)
Ptc Therapeutics (PTCT) posted EBIT Margin of 41.32% for Q2 2026, up 60.87 percentage points from -19.54% a year earlier and up 24.83 percentage points from the prior quarter.
Powered by 
Analysis
Ptc Therapeutics (PTCT) EBIT Margin (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Ptc Therapeutics was 12.45%, down 28.25 percentage points year-over-year; for FY2025, it came in at 50.09%, up 87.60 percentage points from FY2024.
- Annual EBIT Margin has increased for five consecutive years, with a five-year change of +163.49 percentage points (FY2020 to FY2025).
- In prior years, Ptc Therapeutics' EBIT Margin was -37.50% in FY2024 (+9.36 pp), -46.86% in FY2023 (+17.16 pp), -64.03% in FY2022 (+5.50 pp) and -69.52% in FY2021 (+43.87 pp).
- The Q2 2026 figure stands as the highest quarterly EBIT Margin since Q1 2025.
- On a year-over-year basis, EBIT Margin increased in six of the last eight quarters, with an average year-over-year change of +14.66 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2023, with a gain of 121.56 percentage points; the weakest was Q4 2024, with a drop of 78.07 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was 16.50% (Q1 2026), -43.33% (Q4 2025) and 1.43% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Ptc Therapeutics | 5.50 Bn | -2.26 Bn | 340.60 Mn | 41.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.32% |
| Mar 31, 2026 | 16.50% |
| Dec 31, 2025 | -43.33% |
| Sep 30, 2025 | 1.43% |
| Jun 30, 2025 | -19.54% |
| Mar 31, 2025 | 82.50% |
| Dec 31, 2024 | -76.18% |
| Sep 30, 2024 | -27.70% |
| Jun 30, 2024 | -21.54% |
| Mar 31, 2024 | -21.63% |
| Dec 31, 2023 | 1.90% |
| Sep 30, 2023 | -60.11% |
| Jun 30, 2023 | -98.01% |
| Mar 31, 2023 | -53.37% |
| Dec 31, 2022 | -119.67% |
| Sep 30, 2022 | -31.40% |
| Jun 30, 2022 | -55.80% |
| Mar 31, 2022 | -58.17% |
| Dec 31, 2021 | -51.28% |
| Sep 30, 2021 | -67.09% |
API Access
Ptc Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=PTCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "PTCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=PTCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();